Gene Therapy Progress and Prospects: Nonviral vectors
Top Cited Papers
Open Access
- 29 November 2002
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (24) , 1647-1652
- https://doi.org/10.1038/sj.gt.3301923
Abstract
The success of gene therapy is largely dependent on the development of the gene delivery vector. Recently, gene transfection into target cells using naked DNA, which is a simple and safe approach, has been improved by combining several physical techniques, for example, electroporation, gene gun, ultrasound and hydrodynamic pressure. Chemical approaches have been utilized to improve the efficiency and cell specificity of gene transfer. Novel gene carrier molecules, which facilitate DNA escape from the endosome into the cytosol, have been developed. Several functional polymers, which enable controlled release of DNA in response to an environmental change, have also been reported. Plasmids with reduced number of CpG motifs, the use of PCR fragments and the sequential injection method have been established for the reduction of immune response triggered by plasmid DNA. Construction of a long-lasting gene expression system is also an important theme for nonviral gene therapy. To date, tissue-specific expression, self-replicating and integrating plasmid systems have been reported. Improvement of delivery methods together with intelligent design of the DNA itself has brought about large degrees of enhancement in the efficiency, specificity and temporal control of nonviral vectors.Keywords
This publication has 69 references indexed in Scilit:
- Enhanced Cutaneous Gene Delivery Following Intradermal Injection of Naked DNA in a High Ionic Strength SolutionMolecular Therapy, 2002
- Skin-targeted gene transfer using in vivo electroporationGene Therapy, 2001
- Nonviral Gene TherapyCurrent Gene Therapy, 2001
- Nonviral Vectors in the New Millennium: Delivery Barriers in Gene TransferHuman Gene Therapy, 2001
- Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant siteCancer Gene Therapy, 2001
- Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant siteGene Therapy, 2001
- Cutaneous Transfection and Immune Responses to Intradermal Nucleic Acid Vaccination Are Significantly Enhanced by in Vivo ElectropermeabilizationMolecular Therapy, 2001
- Topical gene transfer into rat skin using electroporation.Pharmaceutical Research, 2001
- Theory and in Vivo Application of Electroporative Gene DeliveryMolecular Therapy, 2000
- Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In VivoThe Journal of Immunology, 2000